Related Experiment Video

Updated: May 23, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma

Christopher J Ricketts1, Mark R Morris, Dean Gentle

  • 1Centre for Rare Diseases and Personalized Medicine, University of Birmingham, Birmingham, UK.

Epigenetics
|March 21, 2012
PubMed

Insights

Researchers identified novel tumor suppressor genes (TSGs) in renal cell carcinoma (RCC) through genome-wide methylation profiling. Hypermethylation of genes like OVOL1 and SST was linked to increased tumor growth, suggesting their role in RCC progression.

Area of Science:

  • Oncology
  • Genetics
  • Epigenetics

Background:

  • Renal cell carcinoma (RCC) is a significant health concern.
  • Identifying novel tumor suppressor genes (TSGs) is crucial for understanding RCC development.
  • Epigenetic alterations, particularly DNA methylation, play a role in cancer.

Purpose of the Study:

  • To identify novel candidate tumor suppressor genes (TSGs) in renal cell carcinoma (RCC).
  • To investigate the role of hypermethylated genes in RCC pathogenesis and tumor growth.

Main Methods:

  • Genome-wide methylation profiling using HumanMethylation27 BeadChips on RCC samples.
  • Analysis of methylation status, gene expression, and functional impact of candidate TSGs.
  • RNA interference (RNAi) knockdown to assess gene function in tumor growth.

Main Results:

  • Identified 205 hypermethylated loci/genes in RCC CpG islands.
  • Confirmed frequent tumor methylation, promoter methylation, and transcriptional silencing for several TSGs (e.g., SLC34A2, OVOL1, SST).
  • Demonstrated that OVOL1 and SST knockdown significantly increased anchorage-independent growth, and OVOL1 knockdown elevated c-Myc mRNA levels.

Conclusions:

  • Novel candidate TSGs, including OVOL1 and SST, were identified in RCC.
  • Hypermethylation and subsequent down-regulation of these genes contribute to RCC development and progression.
  • OVOL1 and SST are potential therapeutic targets for renal cell carcinoma.

More Related Videos

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Methyl-binding DNA capture Sequencing for Patient Tissues08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...